Pharma News India

The Indian pharmaceutical industry is growing at a very fast pace. With its fast growth, it is highly imperative to stay updated with the current news and trends in the market. Brand India Pharma gives you the latest pharmacy related news to help you stay updated. Read the latest pharmaceutical news about different sectors and their strategies in the Indian Pharma News section. Get fresh updates from Pharma companies like Natco, Panacea Biotec, Hamsons.
You can bookmark the Indian Pharma News section for the news on pharmaceuticals, drugs and formulations. The Brand India pharmacy news also includes pharmaceutical conference highlights for inquisitive readers.

To assess the impact of Foreign Direct Investment (FDI) on the domestic pharmaceutical companies, a study has been commissioned by the Ministry of Commerce and Industry.

May 29, 2016: An academic expert along with the National Productivity Council would be involved in this exercise. The study is expected to explore the impact of Foreign Direct Investment on the brownfield pharmace...


Dr Reddy's has bought six over the counter (OTC) brands from Ducere Pharma, thus making its entry into the US market.

May 25, 2016: Dr Reddy's has bought six over the counter (OTC) brands from Ducere Pharma, thus making its entry into the US market. Bufferin, Nupercainal ointment, Cruex nail gel, comtrex and myoflex were the brands bought over used to treat cough-and-cold, pain ...


Aurobindo Pharma Limited has received US Food &Drug Administration (USFDA) approval to make and market heartburn relief medicine Famotidine tablets of strengths 10 mg and 20 mg and Oxymorphone Hydrochloride Tablets of strengths 5 mg and 10 mg . The estimated market size for Famotidine for the 12 month period ending February 2016 was US$ 31 million whereas for Oxymorphone Hydrochloride Tablets, ...


Sun Pharma has made acquisitions of 14 established prescription brands from Novartis in Japan worth USD 293 million.

March 29, 2016: A wholly owned subsidiary of Sun Pharma would be acquiring products worth annualised revenues of USD 160 million addressing medical conditions across many therapeutic areas.


The domestic pharma sector posted a growth of 12 per cent in February 2016 on the back of steady volumes, sustained healthy price hikes and new launches as per a report by Religare Institutional Research.

March 14, 2016: The pharmaceutical market research company AIOCD AWACS stated that volumes, prices and new launches contributed 3.7 per cent, 5.4 per cent and 3 per cent respect...


Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...